KeyBank National Association’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $752K | Sell |
1,433
-100
| -7% | -$52.5K | ﹤0.01% | 645 |
|
|
2025
Q1 | $972K | Buy |
1,533
+294
| +24% | +$186K | ﹤0.01% | 559 |
|
|
2024
Q4 | $883K | Buy |
1,239
+76
| +7% | +$54.1K | ﹤0.01% | 590 |
|
|
2024
Q3 | $1.22M | Buy |
1,163
+134
| +13% | +$141K | ﹤0.01% | 514 |
|
|
2024
Q2 | $1.08M | Buy |
1,029
+10
| +1% | +$10.5K | ﹤0.01% | 518 |
|
|
2024
Q1 | $981K | Buy |
1,019
+67
| +7% | +$64.5K | ﹤0.01% | 537 |
|
|
2023
Q4 | $836K | Buy |
952
+35
| +4% | +$30.7K | ﹤0.01% | 577 |
|
|
2023
Q3 | $755K | Sell |
917
-20
| -2% | -$16.5K | ﹤0.01% | 552 |
|
|
2023
Q2 | $673K | Buy |
937
+5
| +0.5% | +$3.59K | ﹤0.01% | 603 |
|
|
2023
Q1 | $766K | Sell |
932
-52
| -5% | -$42.7K | ﹤0.01% | 542 |
|
|
2022
Q4 | $710K | Buy |
984
+85
| +9% | +$61.3K | ﹤0.01% | 558 |
|
|
2022
Q3 | $619K | Sell |
899
-10
| -1% | -$6.89K | ﹤0.01% | 584 |
|
|
2022
Q2 | $537K | Buy |
909
+145
| +19% | +$85.7K | ﹤0.01% | 639 |
|
|
2022
Q1 | $534K | Sell |
764
-105
| -12% | -$73.4K | ﹤0.01% | 698 |
|
|
2021
Q4 | $549K | Buy |
869
+47
| +6% | +$29.7K | ﹤0.01% | 776 |
|
|
2021
Q3 | $497K | Buy |
822
+233
| +40% | +$141K | ﹤0.01% | 796 |
|
|
2021
Q2 | $329K | Buy |
589
+75
| +15% | +$41.9K | ﹤0.01% | 921 |
|
|
2021
Q1 | $243K | Sell |
514
-180
| -26% | -$85.1K | ﹤0.01% | 987 |
|
|
2020
Q4 | $335K | Buy |
694
+40
| +6% | +$19.3K | ﹤0.01% | 875 |
|
|
2020
Q3 | $366K | Buy |
654
+215
| +49% | +$120K | ﹤0.01% | 783 |
|
|
2020
Q2 | $274K | Sell |
439
-448
| -51% | -$280K | ﹤0.01% | 833 |
|
|
2020
Q1 | $433K | Buy |
887
+92
| +12% | +$44.9K | ﹤0.01% | 661 |
|
|
2019
Q4 | $299K | Sell |
795
-21
| -3% | -$7.9K | ﹤0.01% | 858 |
|
|
2019
Q3 | $226K | Sell |
816
-39
| -5% | -$10.8K | ﹤0.01% | 910 |
|
|
2019
Q2 | $268K | Sell |
855
-55
| -6% | -$17.2K | ﹤0.01% | 898 |
|
|
2019
Q1 | $374K | Sell |
910
-68
| -7% | -$27.9K | ﹤0.01% | 778 |
|
|
2018
Q4 | $365K | Sell |
978
-1,664
| -63% | -$621K | ﹤0.01% | 739 |
|
|
2018
Q3 | $1.07M | Buy |
2,642
+73
| +3% | +$29.5K | 0.01% | 532 |
|
|
2018
Q2 | $886K | Buy |
2,569
+1,255
| +96% | +$433K | 0.01% | 588 |
|
|
2018
Q1 | $452K | Buy |
1,314
+37
| +3% | +$12.7K | ﹤0.01% | 775 |
|
|
2017
Q4 | $480K | Sell |
1,277
-988
| -44% | -$371K | ﹤0.01% | 760 |
|
|
2017
Q3 | $1.01M | Sell |
2,265
-9
| -0.4% | -$4.03K | 0.01% | 552 |
|
|
2017
Q2 | $1.12M | Buy |
2,274
+68
| +3% | +$33.4K | 0.01% | 551 |
|
|
2017
Q1 | $855K | Sell |
2,206
-49
| -2% | -$19K | 0.01% | 660 |
|
|
2016
Q4 | $828K | Buy |
2,255
+70
| +3% | +$25.7K | 0.01% | 665 |
|
|
2016
Q3 | $878K | Buy |
2,185
+278
| +15% | +$112K | 0.01% | 641 |
|
|
2016
Q2 | $666K | Sell |
1,907
-1,028
| -35% | -$359K | ﹤0.01% | 684 |
|
|
2016
Q1 | $1.06M | Buy |
2,935
+47
| +2% | +$16.9K | 0.01% | 521 |
|
|
2015
Q4 | $1.57M | Buy |
2,888
+41
| +1% | +$22.3K | 0.01% | 414 |
|
|
2015
Q3 | $1.32M | Buy |
2,847
+311
| +12% | +$145K | 0.01% | 474 |
|
|
2015
Q2 | $1.29M | Sell |
2,536
-19
| -0.7% | -$9.7K | 0.01% | 525 |
|
|
2015
Q1 | $1.15M | Sell |
2,555
-70
| -3% | -$31.6K | 0.01% | 578 |
|
|
2014
Q4 | $1.08M | Buy |
2,625
+116
| +5% | +$47.6K | 0.01% | 593 |
|
|
2014
Q3 | $905K | Sell |
2,509
-3,091
| -55% | -$1.11M | 0.01% | 655 |
|
|
2014
Q2 | $1.58M | Buy |
5,600
+523
| +10% | +$148K | 0.01% | 496 |
|
|
2014
Q1 | $1.53M | Sell |
5,077
-899
| -15% | -$270K | 0.01% | 500 |
|
|
2013
Q4 | $1.65M | Sell |
5,976
-82
| -1% | -$22.6K | 0.01% | 477 |
|
|
2013
Q3 | $1.9M | Sell |
6,058
-865
| -12% | -$271K | 0.01% | 407 |
|
|
2013
Q2 | $1.56M | Buy |
+6,923
| New | +$1.56M | 0.01% | 686 |
|